Why the Amlitelimab Setback Isn’t Enough to Sink Sanofi’s Multi-Billion Dollar Engine

This is a summary. Read the complete story at Yahoo Finance below.

Related Stories

marketsabout 4 hours ago

Cars have become unaffordable for many Americans. Here’s what the numbers show.

At today’s prices and rates, even the average used vehicle can exceed some commonly used affordability measures.

MarketWatch

marketsabout 7 hours ago

Google shows it’s not out of the AI race just yet

The company’s Gemini 4 Argon announcement shows Google is back with the pack when it comes to cutting-edge AI models.

MarketWatch

marketsabout 9 hours ago

The 15 worst-performing S&P 500 stocks during a dismal September

The S&P 500 has gained slightly in September, but three-quarters of its components have declined.

MarketWatch